Showing 1 - 8 results of 8 for search 'Lyna Haybout', query time: 0.30s
Refine Results
-
1
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartmen... by Santeri Pakola, Dafne C. A. Quixabeira, Dafne C. A. Quixabeira, Tatiana V. Kudling, James H. A. Clubb, James H. A. Clubb, Susanna Grönberg-Vähä-Koskela, Susanna Grönberg-Vähä-Koskela, Saru Basnet, Elise Jirovec, Elise Jirovec, Victor Arias, Lyna Haybout, Lyna Haybout, Camilla Heiniö, Joao M. Santos, Joao M. Santos, Victor Cervera-Carrascon, Victor Cervera-Carrascon, Riikka Havunen, Riikka Havunen, Marjukka Anttila, Akseli Hemminki, Akseli Hemminki, Akseli Hemminki
Published 2023-07-01
Article -
2
805 Oncolytic adenovirus encoding human interleukin-7 in combination with ICIs as a treatment strategy against renal cell carcinoma (RCC) by Akseli Hemminki, Víctor Cervera-Carrascón, Otto Hemminki, João Manuel Santos, Saru Basnet, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Susanna AM Grönberg-Vähä-Koskela, Victor Arias
Published 2023-11-01Article -
3
806 Oncolytic adenovirus coding for human Mucin1 T cell engager with interleukin-2 potentiates anti-tumor T cell responses against tumors by Akseli Hemminki, Anna Kanerva, João Manuel Santos, Saru Basnet, Santeri A Pakola, James Clubb, Elise Jirovec, Tatiana Kudling, Lyna Haybout, Mirte Van der Heijden, Susanna AM Grönberg-Vähä-Koskela, Victor Arias, Dafne Alves Quixabeira
Published 2023-11-01Article -
4
739 Emerging proteomic and safety analysis of blood from solid tumor patients receiving TILT-123 (Ad5/3-E2F-d24-hTNFa-IRES-hIL2) monotherapy in TUNIMO phase 1 clinical trial by Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Published 2023-11-01Article -
5
745 Immune cell profiling of advanced-stage solid tumors patients treated with an oncolytic adenovirus encoding for TNF-a and IL-2 (TILT-123) by Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Susanna Juteau, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Published 2023-11-01Article -
6
711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials by Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, Riikka Havunen, João Manuel Santos, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Published 2023-11-01Article -
7
1518 T-cell inducing oncolytic virus (igrelimogene litadenorepvec; TILT-123) shows safety, anti-tumor activity and induction of immune responses in advanced solid tumor patients (f... by Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Susanna Juteau, Marjut Jaakkola, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Lyna Haybout, Claudia Kistler, Tatiana V Kudling
Published 2023-11-01Article -
8
749 Early phase oncology experience on the use of an oncolytic adenovirus encoding for TNFa and IL-2 for the treatment of solid tumors – Interim results by Marco Donia, Tuomo Alanko, Akseli Hemminki, Víctor Cervera-Carrascón, João Santos, Riikka Havunen, Eva Ellebaek, Brigitte Dreno, Inge Svane, Amir Khammari, Juha Kononen, Jorma Sormunen, Katriina Peltola, Riitta Korpisaari, Susanna Juteau, Marjut Jaakkola, Tine Monberg, Suvi Sorsa, Santeri A Pakola, James Clubb, Elise Jirovec, Dafne CA Quixabeira, Tatiana Kudling, Lyna Haybout, Claudia Kistler
Published 2023-11-01Article